Michelle Mellion
Corporate Officer/Principal en PEPGEN INC. .
Fortuna: - $ al 30/04/2024
Perfil
Michelle L.
Mellion is a professional with experience in the pharmaceutical industry.
She is currently the Senior Vice President-Clinical Development at PepGen Inc. Prior to this, she worked as an Executive Medical Director at Fulcrum Therapeutics, Inc. from 2018 to 2022.
She also worked as a Medical Director at Vertex Pharmaceuticals, Inc. from 2016 to 2018 and as an Associate Medical Director at Biogen, Inc. from 2015 to 2016.
Dr. Mellion holds a doctorate degree from Wake Forest University and an undergraduate degree from Colgate University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PEPGEN INC.
-.--% | 31/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Michelle Mellion
| Empresas | Cargo | Inicio |
|---|---|---|
| PEPGEN INC. | Corporate Officer/Principal | 01/04/2022 |
Antiguos cargos conocidos de Michelle Mellion.
| Empresas | Cargo | Fin |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Director Técnico/Científico/I+D | 01/08/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01/11/2016 |
Formación de Michelle Mellion.
| Wake Forest University | Doctorate Degree |
| Colgate University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| PEPGEN INC. | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| BIOGEN INC. | Health Technology |
- Bolsa de valores
- Insiders
- Michelle Mellion
